Share on StockTwits

Vascular Solutions (NASDAQ:VASC) Insider Timothy Slayton sold 1,390 shares of Vascular Solutions stock in a transaction that occurred on Thursday, April 24th. The shares were sold at an average price of $23.15, for a total value of $32,178.50. Following the completion of the transaction, the insider now directly owns 9,265 shares in the company, valued at approximately $214,485. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Vascular Solutions (NASDAQ:VASC) traded up 1.32% during mid-day trading on Monday, hitting $23.06. The stock had a trading volume of 87,473 shares. Vascular Solutions has a one year low of $13.92 and a one year high of $28.21. The stock has a 50-day moving average of $25.04 and a 200-day moving average of $22.79. The company has a market cap of $392.4 million and a price-to-earnings ratio of 35.02.

Vascular Solutions (NASDAQ:VASC) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $0.16 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.18 by $0.02. The company had revenue of $29.91 million for the quarter, compared to the consensus estimate of $29.91 million. During the same quarter in the prior year, the company posted $0.16 earnings per share. The company’s quarterly revenue was up 14.7% on a year-over-year basis. On average, analysts predict that Vascular Solutions will post $0.72 earnings per share for the current fiscal year.

Separately, analysts at Canaccord Genuity raised their price target on shares of Vascular Solutions from $25.00 to $28.50 in a research note on Wednesday, February 5th.

Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.